SHWZ — Medicine Man Technologies Balance Sheet
0.000.00%
Consumer DefensivesHighly SpeculativeMicro Cap
- $0.00m
- $137.10m
- $172.45m
Annual balance sheet for Medicine Man Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11.9 | 1.23 | 106 | 39.4 | 19.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.17 | 1.8 | 3.87 | 4.48 | 4.26 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 15.6 | 6 | 124 | 71.7 | 53.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.299 | 5.16 | 18.8 | 45.3 | 65.3 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 32.2 | 70.7 | 285 | 323 | 358 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.58 | 12.4 | 45.3 | 47.4 | 55.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.65 | 28.9 | 151 | 191 | 239 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 26.6 | 41.8 | 134 | 132 | 119 |
| Total Liabilities & Shareholders' Equity | 32.2 | 70.7 | 285 | 323 | 358 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |